TWIN HEALTH SECURES $50M TO EXPAND ITS GROUNDBREAKING WHOLE BODY DIGITAL TWIN™ TECHNOLOGY AND SERVICE TO REVERSE CHRONIC METABOLIC DISEASE
Summary
Notable achievements include completing the worlds first randomized controlled trial (RCT) for reversing chronic metabolic disease using digital twin technology. The study demonstrated an average of 16.3 lbs in weight loss and 64% of members witnessed a normalization of their baseline non-alcoholic fatty liver disease (NAFLD). "Today, a large and growing number of people around the world are suffering from chronic metabolic disease including type-2 diabetes, pre-diabetes, and obesity. Twins innovative approach combines advanced technology, machine learning, and compassionate care to change the lives of these people. Twin is delivering on its promise of happier and healthier people with significant cost savings to households and employer healthcare plans.